NCI 9448: Phase I study of trametinib in combination with chemoradiation for KRAS-mutant non-small cell lung cancer.
2015
TPS7585 Background: Concurrent chemoradiotherapy is the standard management approach for unresectable, non-metastatic locally advanced non-small cell lung cancer (NSCLC). However, progress has been...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI